STALICLA SA

Swiss Biotech Association

Member

Swiss clinical stage biopharmaceutical company leading omics-based precision medicine drug development platform targeting neurodevelopmental disorders (NDDs), with a first application in Autism Spectrum Disorder (ASD).

http://www.stalicla.com

Location

Avenue de Sécheron 15, 1202 Geneva, Switzerland

Get Directions

Facts & figures

Type of organization

Private company
Year of foundation

2017
Number of employees in Switzerland

10-19

Key business

Core competencies

You may also be interested in

Trialize AG

Revolutionizing clinical trials, Trialize's cutting-edge automation platform accelerates study build times by 4x and curbs manual labor by up to 73%, enhancing data quality, patient adherence, and team morale. It's a game-changer in modern, decentralized, and virtual studies.
6300 Zug

Member

CELLnTEC Advanced Cell Systems

CELLnTEC technologies enable science and industry to develop innovations in stem cell research, regenerative medicine, cell-based therapies, and beyond. The company is a pioneering developer of chemically defined, animal and human components-free precision media.
3014 Bern

Member

INCAPTEK Sàrl

We at INCAPTEK are developing advanced drug delivery systems. We deliver drugs at the right place, in the right dosage, and at the right time. Our smart, programmed-shell micro(nano)capsules can be used for controlled and targeted drug delivery for both biotech and medtech.
1204 Geneva

Member